FDA Will Limit Covid-19 Vaccines To Those Over 65 Or At High Risk

In this week’s edition of InnovationRx, we look at the FDA’s new Covid-19 vaccine rules, Novartis’s acquisition strategy, Medtronic’s diabetes spinoff, Regeneron’s purchase of 23AndMe, and more. To get it in your inbox, subscribe here.